Increase of liver stiffness and altered bile acid metabolism after triple CFTR modulator initiation in children and young adults with cystic fibrosis

A Schnell, J Jüngert, D Klett, H Hober… - Liver …, 2023 - Wiley Online Library
Background Novel cystic fibrosis transmembrane conductance regulator (CFTR) modulator
therapies (elexacaftor/tezacaftor/ivacaftor—ETI) promise clinically significant and sustained …
被引用次数：12 相关文章

Increase of liver stiffness and altered bile acid metabolism after triple CFTR modulator initiation in children and young adults with cystic fibrosis

A Schnell, J Jüngert, D Klett… - … : official journal of …, 2023 - pubmed.ncbi.nlm.nih.gov
Background Novel cystic fibrosis transmembrane conductance regulator (CFTR) modulator
therapies (elexacaftor/tezacaftor/ivacaftor-ETI) promise clinically significant and sustained …

Increase of liver stiffness and altered bile acid metabolism after triple CFTR modulator initiation in children and young adults with cystic fibrosis.

A Schnell, J Jüngert, D Klett, H Hober… - Liver …, 2023 - search.ebscohost.com
Background: Novel cystic fibrosis transmembrane conductance regulator (CFTR) modulator
therapies (elexacaftor/tezacaftor/ivacaftor—ETI) promise clinically significant and sustained …

Increase of liver stiffness and altered bile acid metabolism after triple CFTR modulator initiation in children and young adults with cystic fibrosis.

A Schnell, J Jüngert, D Klett, H Hober… - … : Official Journal of the …, 2023 - europepmc.org
Novel cystic fibrosis transmembrane conductance regulator (CFTR) modulator therapies
(elexacaftor/tezacaftor/ivacaftor-ETI) promise clinically significant and sustained …